FDA.reportPublic FDA data

NDC 66288-4100-01 - Cefoxitin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
66288-4100
Requested NDC
66288-4100-01
Package NDCs from labels
66288-4100-1, 66288-4100-01
Manufacturer
SAMSON MEDICAL TECHNOLOGIES LLC | ACS DOBFAR SPA
Effective date
2020-11-16
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cefoxitin - SAMSON MEDICAL TECHNOLOGIES LLC | ACS DOBFAR SPASAMSON MEDICAL TECHNOLOGIES LLC | ACS DOBFAR SPA2020-11-16HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
66288-4100-1Cefoxitin1 in 1 BAGINJECTION, POWDER, FOR SOLUTION13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
66288-4100CEFOXITIN INJECTION, POWDER, FOR SOLUTION [SAMSON MEDICAL TECHNOLOGIES LLC]3Current NDC, Legacy NDC, 1 package rows20201120_ea6dba56-5d9c-463a-b1d9-f7af5b602ed9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 11 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefoxitinCEFOXITINWG Critical Care, LLC658a0dc6-6da5-44dc-94f2-1211619297f72026-08-24Warnings, Adverse reactionsExact identifier
unii: Q68050H03T
CefoxitinCEFOXITINWG Critical Care, LLC91ac4c14-8dd8-4efe-a462-d1c488a6184f2025-11-12Warnings, Adverse reactionsExact identifier
unii: Q68050H03T
CefoxitinCEFOXITINHikma Pharmaceuticals USA Inc.6a4a2afa-4f00-41d4-bd6d-baa0a95f69292025-03-03Warnings, Adverse reactionsExact identifier
unii: Q68050H03T
CefoxitinCEFOXITINHikma Pharmaceuticals USA Inc.d2c449b9-5624-4166-95b1-d7813b3d04452024-04-11Warnings, Adverse reactionsExact identifier
unii: Q68050H03T
CefoxitinCEFOXITINSagent Pharmaceuticalsb272ef9c-4d83-4ee2-b9cc-477440822cca2024-01-03Warnings, Adverse reactionsExact identifier
unii: Q68050H03T
CefoxitinCEFOXITINWG Critical Care, LLCf5288962-caee-4771-8229-df9cdefcfa672023-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: Q68050H03T
CefoxitinCEFOXITIN SODIUMFresenius Kabi USA, LLC2a9d1e7b-96ee-4e6c-a1e8-47b76b9244222023-07-10Warnings, Adverse reactionsExact identifier
unii: Q68050H03T
CefoxitinCEFOXITIN SODIUMFresenius Kabi USA, LLCd02170ff-65aa-48b8-a922-94271c46ffa72022-09-23Warnings, Adverse reactionsExact identifier
unii: Q68050H03T
CefoxitinCEFOXITINSAMSON MEDICAL TECHNOLOGIES LLCea6dba56-5d9c-463a-b1d9-f7af5b602ed92020-11-16Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA200938
ndc (package): 66288-4100-1
ndc (product): 66288-4100
ndc11 (package): 66288410001
rxcui: 1739890
spl id: b137208d-8dfd-4133-94c2-7287866a5525
spl set id: ea6dba56-5d9c-463a-b1d9-f7af5b602ed9
unii: Q68050H03T
CefoxitinCEFOXITINSagent Pharmaceuticals4c6f7665-204f-6c69-7669-61204d756e6e2020-06-09Boxed warning, Warnings, Adverse reactionsExact identifier
unii: Q68050H03T
Cefoxitin and DextroseCEFOXITIN SODIUMB. Braun Medical Inc.6c7e9485-1ede-411c-8c46-9114393328642019-07-29Warnings, Adverse reactionsExact identifier
unii: Q68050H03T

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.